Drug Legalization Series

All posts · Reentry & Policy · Recovery · Topics

1. Part 1

   Drug Legalization Series Part 1: Drug Legalization Isn’t Endorsement. It’s Regulation and Harm Reduction.

   Drug legalization isn’t endorsement. Part 1 explains why punishment fails, why reentry is deadly, and why harm reduction saves lives.

   January 9, 2026

2. Part 1.5

   Drug Legalization Series Part 1.5: Legalization vs Decriminalization vs Regulation: Drug Policy Explained

   Legalization isn’t one policy. This post explains legalization vs decriminalization vs regulation, and what strict regulation actually delivers in safety and outcomes.

   January 13, 2026

3. Part 2

   Drug Legalization Series Part 2: How Drug Criminalization Creates a Permanent Underclass

   Drug felony consequences go far beyond court. Here’s how felony drug possession consequences create employment and housing barriers, crush credit, and trap people long after release.

   January 14, 2026

4. Part 3

   Drug Legalization Series Part 3: The Hidden Sentence

   Being convicted of a drug felony: voting rights, gun rights, and the permanent sentence that is rarely talked about. Part 3 in the drug legalization series.

   January 17, 2026

5. Part 4

   Drug Legalization Series Part 4: What Drug Legalization and Regulation Actually Buys Us

   Drug legalization and regulation is not endorsement. It is a regulated drug supply with testing, labeling, fentanyl test strips, and real accountability that prohibition cannot deliver.

   January 20, 2026

6. Part 5

   Drug Legalization Series Part 5: How Illegal Drug Markets Power Gangs and Cartels

   Drug prohibition violence is not an accident. It is a predictable result of illegal markets. How gangs and drug trafficking, cartel revenue, and drug market violence grow under prohibition.

   January 22, 2026

7. Part 6

   Drug Legalization Series Part 6: Tusi (Pink Cocaine), Xylazine, and THC Analogues: Why Enforcement Can’t Keep Up

   Tusi (pink cocaine), xylazine, medetomidine, nitazenes, and THC analogues prove enforcement can’t keep up. Regulation creates testing, labeling, and accountability.

   January 26, 2026

8. Part 7

   Drug Legalization Series Part 7: Recovery Lockbox: Fund Addiction Treatment Without Raising Taxes

   A recovery lockbox captures enforcement savings and regulated-market revenue to fund MOUD, recovery housing, and reentry using National Drug Control Budget FY 2025 realities and real jail costs.

   February 3, 2026

9. Part 8

   Drug Legalization Series Part 8: Fear Is Not a Policy: The Known Failure vs the Imagined Risk

   In part 8 of the drug legalization blog series, we explore fear-based drug policy, Oregon's Measure 110 results, and what effective policy would entail.

   February 9, 2026

10. Part 9

    Drug Legalization Series Part 9: What Regulation Would Actually Look Like

    This post explains what risk-based drug regulation looks like in practice: a risk-tier model built around supply control, age limits, potency limits, licensing, taxation, enforcement priorities, and the recovery infrastructure required to make it real.

    February 16, 2026

11. Part 10

    Drug Legalization Series Part 10: With Drug Legalization, Accountability Still Exists

    In part 10 of the drug legalization and regulation series, we explore how drug legalization accountability answers a hard question: what gets enforced when use isn’t a crime, and how a regulated drug market protects the public.

    February 24, 2026

12. Part 11

    Drug Legalization Series Part 11: Prevention That Isn’t Propaganda

    Evidence-based drug prevention programs beat scare tactics—here’s what actually reduces youth drug use, why fear-based drug education fails, and how prevention fits inside drug legalization and strict regulation.

    March 4, 2026

13. Part 12

    Drug Legalization Series Part 12: The Reentry Window We Keep Wasting

    Prison release overdose risk is highest in the first days and weeks after release. This chapter explains which pre-release and post-release programs actually reduce overdose, recidivism, and instability.

    March 10, 2026

14. Part 13

    Drug Legalization Series Part 13: Mental Health, Housing, and Despair

    We explore the connection between drug addiction and homelessness, mental illness, and housing first addiction recovery in part 13 of the drug legalization and regulation series.

    March 18, 2026

15. Part 14

    Drug Legalization Series Part 14: A Regulated Pharmacy Model for High-Risk Substances

    A regulated pharmacy model for high-risk substances could replace street chaos with standards, cut overdose risk, and connect people to treatment on demand fast.

    March 27, 2026

16. Part 15

    Drug Legalization Series Part 15: Arguments Against Drug Legalization: The Hard Objections, Answered Directly

    The strongest arguments against drug legalization deserve direct answers. This post breaks down drug legalization pros and cons, youth access, public safety, mental health, and whether legalization actually increases drug use.

    March 30, 2026

17. Part 16

    Drug Legalization Series Part 16: How to Run a Drug Legalization Pilot Program Without Betting the Farm

    Part 16 lays out a drug legalization pilot program framework that pilots risk-based drug regulation, measures overdose prevention and public safety outcomes, and scales only what works with strong diversion control, 42 CFR Part 2 privacy, and outcomes-based funding.

    April 7, 2026

18. Part 17

    Drug Legalization Series Part 17: Case Studies Without Cherry-Picking

    Part 17 uses real drug policy case studies to examine what worked, what failed, and why across Portugal drug decriminalization, Oregon Measure 110 results, British Columbia safer supply, Switzerland heroin-assisted treatment, and cannabis legalization outcomes.

    April 14, 2026

19. Part 18

    Drug Legalization Series Part 18: Ditching Moral Panic For A Public Health Approach

    Part 18 makes the case for a public health approach to drug policy over moral panic, using harm reduction strategies, overdose prevention, addiction stigma reduction, and risk-based drug regulation to reduce death, disorder, and failed policy.

    April 24, 2026

20. Part 19

    Drug Legalization Series Part 19: The Myth That Regulation Is Too Complex to Run

    Part 19 explains why controlled substance regulation is already being administered every day through prescription drug monitoring program systems, methadone clinic regulations, buprenorphine prescribing rules, pharmacy oversight, and the regulated pharmacy model logic behind risk-based reform.

    May 3, 2026